Targeted Elimination of
antimicrobial resistance
eliminating efficiency
plasmid conjugation
re-sensitization
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
01
2022
accepted:
19
03
2022
entrez:
15
4
2022
pubmed:
16
4
2022
medline:
16
4
2022
Statut:
epublish
Résumé
Plasmid-borne carbapenem resistance gene A series of CRISPR-Cas9 plasmids was constructed, and specific guide RNAs(sgRNA) were designed to target the The results showed that pCas9, pCas9-oriT and pBAD-Cas9-oriT can effectively eliminate The CRISPR-Cas9 system achieved plasmid clearance and simultaneous re-sensitization to meropenem in
Identifiants
pubmed: 35422639
doi: 10.2147/IDR.S357470
pii: 357470
pmc: PMC9004731
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1707-1716Informations de copyright
© 2022 Li et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Nat Biotechnol. 2014 Nov;32(11):1141-5
pubmed: 25240928
J Antimicrob Chemother. 2019 Sep 1;74(9):2559-2565
pubmed: 31203365
Infect Drug Resist. 2020 Nov 02;13:3929-3935
pubmed: 33173318
Appl Environ Microbiol. 1999 Aug;65(8):3710-3
pubmed: 10427070
Infect Drug Resist. 2020 Apr 22;13:1171-1178
pubmed: 32368108
Int J Antimicrob Agents. 2019 Jan;53(1):1-8
pubmed: 30267758
Front Microbiol. 2020 Apr 30;11:578
pubmed: 32425894
J Antimicrob Chemother. 2021 Dec 24;77(1):74-82
pubmed: 34613377
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Gene. 1995 Dec 1;166(1):175-6
pubmed: 8529885
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0105421
pubmed: 34339270
J Bacteriol. 1995 Jul;177(14):4121-30
pubmed: 7608087
Nucleic Acids Res. 2021 Apr 6;49(6):3584-3598
pubmed: 33660775
Biosci Rep. 2013 Dec 12;33(6):
pubmed: 24229075
Lipids Health Dis. 2019 Mar 18;18(1):69
pubmed: 30885208
PLoS One. 2013;8(2):e57923
pubmed: 23460914
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7267-72
pubmed: 26060300
Nat Microbiol. 2019 Sep;4(9):1432-1442
pubmed: 31439928
Clin Infect Dis. 1998 Aug;27 Suppl 1:S12-20
pubmed: 9710667
Sci Rep. 2016 Nov 24;6:37895
pubmed: 27883076
JACC Basic Transl Sci. 2016 Apr 25;1(3):170-179
pubmed: 30167510
Antimicrob Agents Chemother. 2020 Aug 20;64(9):
pubmed: 32631827
Pharmaceutics. 2021 Mar 08;13(3):
pubmed: 33800235
FEMS Microbiol Rev. 2018 Nov 1;42(6):781-804
pubmed: 30085063
Nat Commun. 2019 Oct 4;10(1):4544
pubmed: 31586051
Can J Microbiol. 2019 Jan;65(1):34-44
pubmed: 30248271
Environ Pollut. 2021 Jan 2;273:116370
pubmed: 33460870
Drug Deliv. 2018 Nov;25(1):1234-1257
pubmed: 29801422
Microb Cell Fact. 2017 Aug 2;16(1):135
pubmed: 28764701
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31527030
Theranostics. 2020 May 15;10(14):6310-6321
pubmed: 32483454
Nucleic Acids Res. 2016 Nov 2;44(19):e149
pubmed: 27458201
J Bacteriol. 2012 Jul;194(14):3742-3
pubmed: 22740669
Infect Drug Resist. 2019 Sep 24;12:3029-3038
pubmed: 31576153
Infect Drug Resist. 2020 Apr 22;13:1163-1169
pubmed: 32368107
Pharmaceutics. 2021 Oct 09;13(10):
pubmed: 34683943
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
PLoS One. 2014 Mar 03;9(3):e90372
pubmed: 24595202
Nat Biotechnol. 2014 Nov;32(11):1146-50
pubmed: 25282355